Xtant Medical shares are trading higher after the company announced it launched OsteoVive Plus, a moldable viable bone matrix that can be used in a variety of grafting procedures.
Portfolio Pulse from Benzinga Newsdesk
Xtant Medical shares rose following the launch of OsteoVive Plus, a new moldable viable bone matrix for grafting procedures.
September 18, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Xtant Medical's stock price increased after the company announced the launch of OsteoVive Plus, a new product that enhances its offerings in the medical field.
The launch of a new product, OsteoVive Plus, is likely to boost investor confidence and drive demand for Xtant Medical's offerings, leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100